Industries > Pharma > The Molecular Diagnostics (MDx) Market Forecast 2017-2027

The Molecular Diagnostics (MDx) Market Forecast 2017-2027

Infectious Disease Testing, Oncology Testing, Blood Screening, Genetic Testing, Tissue Typing

PUBLISHED: 08 August 2017
PAGES: 206
PRODUCT CODE: PHA0222

Clear
WOOCS 2.2.1

The molecular diagnostics (MDx) market was worth $6.13bn in 2016 and is estimated to grow at a CAGR of 12.5% from 2017-2021. The fastest growing segment of the molecular diagnostics market over the forecast period 2017-2027 will be the oncology testing segment. The segment was worth $1.08bn in 2016 and represented 17.6% of the molecular diagnostics market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 206-page report you will receive 135 charts – all unavailable elsewhere.

The 206-page report provides clear detailed insight into the molecular diagnostics (MDx) market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

World IVD market forecasts from 2017-2027

Molecular diagnostics (MDx) market forecasts from 2017-2027

The Molecular Diagnostics (MDx) Market Forecast 2017-2027

Revenue and growth forecasts to 2027 for the leading submarkets:
• Infectious Disease Testing
• Oncology Testing
• Blood Screening
• Genetic Testing
• Tissue Typing

• This report provides individual revenue forecasts to 2027 for these regional and national markets:
– US
– Europe:
• Germany
• UK
• Spain
• Italy
• France
• Rest of Europe
– Japan
– China
– Brazil
– Russia
– India
– South Korea
– Mexico
– RoW

• This report discusses the leading companies in the molecular diagnostics (MDx) market:
• Roche Diagnostics
• Qiagen
• Hologic
• Becton, Dickinson & Company
• bioMérieux
• Agilent Technologies

A company profile gives you the following information where available:
• Discussion of a company’s activities and outlook
• Analysis of assays and instruments currently on the market as well as pipeline products
• Acquisitions and strategic partnerships

• This report discusses the SWOT analysis as well as porter’s five forces analysis of the molecular diagnostics (MDx) market

Visiongain’s study is intended for anyone requiring commercial analyses for the molecular diagnostics (MDx). You find data, trends and predictions.

Buy our report today The Molecular Diagnostics (MDx) Market Forecast 2017-2027: Infectious Disease Testing, Oncology Testing, Blood Screening, Genetic Testing, Tissue Typing.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for The Molecular Diagnostics (MDx) Market Forecast 2017-2027


Download sample pages

Complete the form below to download your free sample pages for The Molecular Diagnostics (MDx) Market Forecast 2017-2027


Latest Pharma news

Visiongain Publishes Meningococcal Vaccines Market Report 2021-2031

Meningococcal diseases is caused by a type of bacteria, it can lead to an infection of the bloodstream or meningitis, or both, and can be life taking if not quickly treated. The meningococcal conjugate vaccines are very affective at protecting against four strains of the bacteria while the MenB vaccine protects against a fifth strain.

29 October 2020

READ

Visiongain Publishes Inspection Machine Market Report 2021-2031

Supervisory obligations in the healthcare industry to sustain compliance with good manufacturing practices, growing number of inspection frontiers in production lines, growing number of product evokes, rising dispersion of automated inspection systems in the pharmaceutical & biotechnology industries, and technological advancement in inspection systems are the major aspects driving the growth of this market.

29 October 2020

READ

Visiongain Publishes Hydrophobic Interaction Chromatography Market Report 2021-2031

Global Hydrophobic Interaction Chromatography (HIC) is one of the most extensively used methods for splitting and cleansing proteins in their native state. HIC also proves to be quite useful in isolating protein complexes and in studying protein folding and unfolding.

29 October 2020

READ

Visiongain Publishes Hemostats and Sealants Market Report 2021-2031

Rise in the occurrences of chronic conditions of elderly population has boosted the growth of the Hemostats and Sealants market, globally. According to the Centres for Disease Control and Prevention (CDC) statistics, over 45% of American population suffers from at least one chronic condition needing critical care. Thus, these factors are impacting the market towards a positive growth.

29 October 2020

READ

Categories

Category